Serum Life Sciences Ltd, a unit of India-based SII, will pick up a 3.9% stake in Oxford Biomedica as part of the deal. Oxford Biomedica, spun off from Oxford University in 1995, said it would use the funds to develop the fallow area at its Oxbox plant into a manufacturing space expected to come online in mid-2023.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3CPnpez
via IFTTT
0 comments:
Post a Comment